Clinical Trial Update: A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

View source ↗

Summary

A completed trial evaluating the relationship between lenalidomide and tumor flare reactions in participants with relapsed or refractory mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Mantle-Cell | Status: COMPLETED